Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Cancers|November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional ExperienceJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.Haematologica|May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donorsRajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.The AAPS Journal|November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemiaHongyan Wang, Ping Chen, Jiang Wang, et al.Transplantation and Cellular Therapy|November 17, 2021
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation RecipientsJeremy D Rubinstein, Sonata Jodele, Daria Heyenbruch, et al.Frontiers in Oncology|March 14, 2022
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell TransplantAudrey M Sigmund, Qiuhong Zhao, Justin Jiang, et al.Journal of Hematology & Oncology|January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trialJorge E Cortes, Gail J Roboz, Maria R Baer, et al.Leukemia|August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study resultsMichael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.Pageof 5